Apalutamide Impurity 13 | CAS 956104-42-0 - Request Quote
Apalutamide Impurity 13
| SZ CAT No: | SZ-A086024 |
| CAS No | 956104-42-0 |
| Mol.F. | C6H2BrF3N2O2 |
| Mol.Wt. | 271.0 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Apalutamide Impurity 13 is chemically 2-Bromo-5-nitro-3-(trifluoromethyl)pyridine. Apalutamide Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Apalutamide Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apalutamide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 956104-42-0
Purchase 956104-42-0
Order 956104-42-0
Enquire 956104-42-0
price of 956104-42-0
956104-42-0 Supplier
956104-42-0 Manufacturer
956104-42-0 Exporter
buy high quality Apalutamide Impurity 13
Purchase Apalutamide Impurity 13
Apalutamide Impurity 13 suppliers
Apalutamide Impurity 13 manufacturers
Apalutamide Impurity 13 price
Order Apalutamide Impurity 13
Enquire Apalutamide Impurity 13
Apalutamide Impurity 13 cost
Apalutamide Impurity 13 Supplier
Apalutamide Impurity 13 Distributor
Apalutamide Impurity 13 for Method Validation
Apalutamide Reference Standard
Apalutamide Impurity 13 for ANDA Filing
Apalutamide Impurity 13 for Forced Degradation Studies
Apalutamide Impurity 13 Identification Standards
Apalutamide Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


